References
- 1. Grappone L, Messina F. Hyaline membrane disease or respiratory distress syndrome? A new approach for an old disease Lidia. Journal of Pediatric and Neonatal Individualized Medicine 2014; 3: e030263.
- 2. Bitterman PB. Pathogenesis of fibrosis in acute lung injury. Am J Med 1992; 92: 39-43.
- 3. Locci G, Fanos V, Gerosa C, Faa G. Hyaline membrane disease (HMD): the role of the perinatal pathologist. Review. Journal of Pediatric and Neonatal Individualized Medicine 2014; 3: e030255.
- 4. Jo HS. Genetic risk factors associated with respiratory distress syndrome. Korean J Pediatr 2014; 57: 157-63.
- 5. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005; 85: 495-522.
- 6. Wang G, Lee HM, Englander E, et al. Ghrelin-not just another stomach hormone. Regul Pept 2002; 105: 75-81.
- 7. Hattori N. Expression, regulation and biological actions of growth hormone (GH) and Ghrelin in the immune system. Growth Horm IGF Res 2009; 19: 187-97.
- 8. Stefanov I, Ananiev J, Ivanova K, et al. Distribution of Ghrelin-positive mast cells in rat stomach. Biotechnology & Biotechnological Equipment 2017; 31: 774-81.
- 9. Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med 2012; 18: 684-92.
- 10. Neil WS. Recent advances in our understanding of human host responses to tuberculosis. Respir Res 2001; 2: 157-163.
- 11. Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 2007; 87: 1047-82.
- 12. Sinnamon MJ, Carter KJ, Sims LP, et al. A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis 2008; 29: 880-86.
- 13. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med 2012; 18: 693-704.
- 14. 14. Boesiger J, Tsai M, Maurer M, et al. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fc epsilon receptor I expression. J Exp Med. 1998; 188: 1135-45.
- 15. Horsmanheimo L, Harvima IT, Jarvikallio A, et al. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994; 131: 348-53.
- 16. Gibbs BF, Arm JP, Gibson K, et al. Human lung mast cells release small amounts of interleukin-4 and tumour necrosis factor-alpha in response to stimulation by antiIgE and stem cell factor. Eur J Pharmacol 1997; 327: 73-78.
- 17. Leon A, Buriani A, Dal Toso R, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994; 91: 3739-43.
- 18. Orinska Z, Maurer M, Mirghomizadeh F, et al. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat Med 2007; 13: 927-34.
- 19. Church MK, Levi-Schaffer F. The human mast cell. J Allergy Clin Immunol 1997; 99: 155-60.
- 20. Abraham SN, Thankavel K, Malaviya R. Mast cells as modulators of host defense in the lung. Front Biosci 1997; 2: 78-87.
- 21. Lan RS, Stewart GA, Henry PJ. Role of protease-activated receptors in airway function: a target for therapeutic intervention? Pharmacol Ther 2002; 95: 239-57.
- 22. Berger P, Girodet PO, Begueret H, et al. Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis. FASEBJ 2003; 17: 2139-41.
- 23. Smith TJ, Hougland MW, Johnson DA. Human lung tryptase. Purification and characterization. J biol Chem 1984; 259: 11046-51.
- 24. McDonald DM, Schoeb TR, Lindsey JR. Mycoplasma infections cause long-lasting potentiation of neurogenic inflammation in the respiratory tract of the rat. J Clin Invest 1991; 87: 787-99.
- 25. Shimada K, Chen S, Dempsey PW, et al. The NOD/RIP2 Pathway Is Essential for Host Defenses Against Chlamydophila pneumoniae Lung Infection. PLoS Pathog 2009; 5: e1000379.
- 26. Rodriguez N, Fend F, Jennen L, et al. Polymorphonuclear neutrophils improve replication of Chlamydia pneumoniae in vivo upon MyD88-dependent attraction. J. Immunol 2005; 174: 4836-44.
- 27. Crother TR, Ma J, Jupelli M, et al. Plasmacytoid dendritic cells play a role for effective innate immune responses during Chlamydia pneumoniae infection in mice. PLoS One 2012; 7: e48655.
- 28. Pesci A, Majori M, Piccoli ML, et al. Mast cells in bronchiolitis obliterans organizing pneumonia. Mast cell hyperplasia and evidence for extracellular release of tryptase. Chest 1996; 110: 383-91.
- 29. Fisher MM, Baldo BA. Mast cell tryptase in anaesthetic anaphylactoid reactions. British Journal of Anaesthesia 1998; 80: 26-9.
- 30. Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 2006; 117: 1277-84.
- 31. Volante M, Fulcheri E, Allìa E, et al. Ghrelin expression in fetal, infant, and adult human lung. J Histochem Cytochem 2002; 50: 1013-21.
- 32. Li B, Zeng M, He W, et al. Ghrelin protects alveolar macrophages against lipopolysaccharide-induced apoptosis through growth hormone secretagogue receptor 1a-dependent c-Jun N-terminal kinase and Wnt/β-catenin signaling and suppresses lung inflammation. Endocrinology 2015; 156: 203-17.
- 33. Waseem T, Duxbury M, Ito H, et al. Exogenous Ghrelin modulates release of pro-inflammatory and anti-inflammatorycytokinesinLPS-stimulatedmacrophagesthroughdistinct signaling pathways. Surgery 2008; 143: 334-342.
- 34. Imazu Y, Yanagi S, Miyoshi K, et al. Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation. Eur J Pharmacol 2011; 672: 153-8.
- 35. Xu X, Zhang D, Lyubynska N, et al. Mast cells protect mice from Mycoplasma pneumonia. Am J Respir Crit Care Med 2006; 173: 219-25.
- 36. Hoek KL, Cassell GH, Duffy LB, et al. Mycoplasma pneumoniaeinduced activation and cytokine production in rodent mast cells. J Allergy Clin Immunol 2002; 109: 470-76.
- 37. Aroni K, Voudouris S, Ioannidis E, et al. Increased angiogenesis and mast cells in the centre compared to the periphery of vitiligo lesions. Arch Dermatol Res 2010; 302: 601-07.